'Sephora kids' trend prompts bill to ban kids from purchasing makeup (again). Here's why.
For the second year in a row, California has introduced a bill that, if passed, would ban minors from purchasing anti-aging beauty products.
The bill follows the ongoing "Sephora kids" trend, in which young people, specifically preteens, purchase and use makeup and skincare products, often with ingredients designed for adults, which can damage the skin's barrier. These kids, usually girls, have been thrust into the spotlight for showcasing their product "hauls" and routines on social media, namely TikTok.
The California bill was introduced in February by Assemblyman Alex Lee, who first brought the bill to California's legislative floor in 2024. The first iteration bill, which would have prohibited children younger than 13 from purchasing anti-aging products, did not pass. Lee introduced it again this year with an even wider age restriction.
Here's what to know about California's bill and what professionals have to say about the harms of children participating in multi-step skincare routines.
If passed, the bill − AB 728 − would make it illegal for businesses to sell anti-aging skincare products to individuals under the age of 18 in the state of California. Specifically, these products include those that contain:
Vitamin A and its byproducts, including retinoids and retinol
Alpha hydroxy acid, including glycolic acid, ascorbic acid (vitamin C) and citric acid
If a seller is unsure of the age of the a customer purchasing an anti-aging product that contains one of the above ingredients, they may ask to verify the customer's age, the bill states.
This type of legislation wouldn't be the first of its kind. In California, you have to be both 21 to purchase alcohol and tobacco products.
The bill introduced last year − AB 2941 − made it through the first necessary committee but then died at the state's finance committee, Lee said. It banned the same ingredients, vitamin A and alpha hydroxy acid, but for children under the age of 13. Dermatologists and parents are concerned kids could be harming their skin in attempt to stay up with impossible beauty standards.
Alpha hydroxy acid, for example, is marketed to smooth wrinkles, improve skin texture and tone and cleanse pores. The acid works by dissolving the bonds between dead skin cells on the surface, which in turns promotes cell turnover. This tends to result in the "shedding" of skin, according to the FDA.
Though alpha hydroxy acid can be used to improve skin firmness and elasticity, skin shedding can also increase the skin's sensitivity, especially to sunlight, according to a 2018 report published in the peer-reviewed journal Molecules. This can result in "serious skin damage."
Vitamin A, on the other hand, hasn't been proven to treat skin conditions like acne, dry skin or winkles, the Mayo Clinic says. Vitamin A is more effective when consumed through dietary sources, including animal products like eggs, dairy products and fish, and plants like orange and yellow fruits and vegetables, and leafy green vegetables.
"Now, it's pretty ridiculous that children are worried about wrinkles and fine lines and buying these products, but it turns out these products can also have a long-term irreversible damage and harm to children," Lee said.
Marisa Garshick is a dermatologist at MDCS Dermatology: Medical Dermatology and Cosmetic Surgery in New York and a mother to a 10-year-old daughter, who is interested in trendy products and routines.
Garshick said she understands it can be hard to say "no," when a child wants the popular new cleanser or exfoliant, but young skin is more sensitive because it hasn't fully developed.
"The things where we start to worry, in terms of sort of wrecking more havoc on the skin or causing more irritation, are these active ingredients like retinol, vitamin C or exfoliating acids," she said. "Within this group of people with sensitive skin, those types of ingredients may cause redness, dryness, flaking, irritation. It can maybe disrupt the skin barrier, which actually makes the skin more sensitive to other things as well."
Retinol, a form of vitamin A, for example, is an active ingredient because it stimulates cells production. It also exfoliates the skin and increases collagen production, which, according to the Cleveland Clinic, can reduce the appearance of wrinkles.
While young people don't typically need products with active ingredients, Garshick said that are some caveats. For example, if Garshick is working with a teen who is struggling with acne, she may prescribe a product with active ingredients like retinoids, benzoyl peroxide or salicylic acid.
"Even though there's definitely subgroups where we would say to avoid certain things, there may be situations where it is actually recommended," Garshick said. "In those settings, we don't necessarily want people to be fearful of using these products."
Young girls having an interest in beauty products isn't a new trend.
"When I was young, it was Lip Smackers. These were heavily-fragranced lip balms that smelled like Coca-Cola or Orange Crush," Shannon Humphrey, clinical associate professor in the University of British Columbia's Department of Dermatology and Skin Science, said.
Today though, young people are further inodiated with what their peers, and those they look up to, are using and promoting on social media.
Videos a part of the "Sephora kids" trend, which gained traction in early 2024, feature young girls swiftly moving around Sephora aisles, shopping baskets in tow, full of beauty products. Beauty stores have been likened to elementary schools, as 10-year-olds run amok, some caught treating employees poorly or destroying displays.
While these chaotic videos of preteens taking over Sephora have come to represent how young girls experience the beauty industry, not all are interested in what's popular on TikTok.
Humphrey said her 12-year-old daughter Viv doesn't have social media, so she mostly has learned about skincare products and routines through her friends at school and of course, her mother. Humphrey said Viv tends to use a light cleanser and moisturizer, sunscreen and lip gloss.
"I asked her about it and without missing a beat, she said it made her feel good and that she loved talking with her friends about what kind of lip gloss they used and what their favorite sunscreen or moisturizer was," Humphrey said on why Viv enjoys skincare products. "It was really a social response. It wasn't one about beauty."
Above and beyond though, Humphrey said every child is different and should be considered as such when it comes to skincare.
Not all skincare products are off the table.
Garshick said across the board, no matter the age, she recommends that everyone wash their face once a day and use a simple moisturizer and sunscreen. Fragrance sprays and lip balms are also okay for younger folks.
"I'd say keep it simple," Humphrey added. "You don't have to break the bank. You don't have to get what's trending on Instagram. There are some excellent cleansers and moisturizers available from the drugstore."
For preteens and teens who have more specialized concerns, like acne, Garshick encouraged a visit to a dermatologist to create a specialized care plan.
Contributing: Katie Camero
Greta Cross is a national trending reporter at USA TODAY. Follow her on X and Instagram @gretalcross. Story idea? Email her at gcross@usatoday.com.
This article originally appeared on USA TODAY: California aims to ban anti-aging products for minors, 'Sephora kids'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
Capricor treatment of Becker muscular dystrophy granted orphan designation
The FDA granted orphan designation to a treatment of Becker muscular dystrophy being developed by Capricor, according to a post to the agency's website. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Yahoo
2 hours ago
- Yahoo
Insmed Inc (INSM) Soars 30% on Impressive Study
We recently published a list of . In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against other top-performing companies on Tuesday. Insmed Inc. soared by 28.65 percent on Tuesday to close at $90.93 apiece following positive results from the phase 2 trial of its pulmonary arterial hypertension (PAH) treatment, treprostinil palmitil inhalation powder (TPIP). Insmed Incorporated (NASDAQ:INSM) jumped as high as 30 percent at intraday trading following the announcement. According to the company, the phase 2 trial achieved its primary and secondary goals for the treatment of reducing blood pressure in the lungs and improving exercise capacity in patients. Following the results, Insmed Incorporated (NASDAQ:INSM) said it would engage with the Food and Drug Administration (FDA) regarding the phase 3 trial design. The company said it plans to initiate a Phase 3 trial in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) before the end of the year, to be followed by a Phase 3 trial in patients in early 2026. A biopharmaceutical research team taking notes in front of a laboratory's microscope. 'These unprecedented Phase 2b results unequivocally demonstrate TPIP's potential to be a highly effective and well-tolerated once-daily prostanoid therapy for the treatment of PAH across disease severities and background treatment regimens. We look forward to expanding upon these results in the upcoming Phase 3 program,' the company said. Overall, INSM ranks 1st on our list of top-performing companies on Tuesday. While we acknowledge the potential of INSM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Insider
3 hours ago
- Business Insider
KalVista says FDA will not meet PDUFA goal date for Sebetralstat NDA
KalVista (KALV) Pharmaceuticals nnounced that the U.S. Food and Drug Administration has notified the company that it will not meet the PDUFA goal date for the New Drug Application for sebetralstat, the company's investigational oral on-demand treatment for hereditary angioedema. The FDA notified the company on June 13, 2025, that the previously disclosed June 17, 2025 PDUFA goal date will not be met due to heavy workload and limited resources. The FDA indicated that it expects to deliver a decision within approximately four weeks. The FDA has not requested additional data or studies and has not raised any concerns regarding the safety, efficacy or approvability of sebetralstat. KalVista has addressed all prior information requests in a timely manner, and the company believes the only remaining item under FDA review is the finalization of the labelling. 'We are disappointed by this delay, most importantly because we know how much people living with HAE are looking forward to an oral on-demand option to treat their HAE attacks,' said Ben Palleiko, CEO of KalVista. 'At the same time, we remain confident in the near-term approval of sebetralstat. We are continuing to work closely with the FDA to support the completion of their review. Our commitment to bringing this important therapy to people living with HAE remains unwavering.'